Skip to main content

Leukemia, lymphoma, and myeloma.

265 studies recruiting right now, most recently updated first.

Open the Phase 2 page · a list of only those studies

Triangle is made by Triangle Health, Inc.

Leukemia, lymphoma, and myeloma265 studies

Relapsed or Refractory Post-Transplant Lymphoproliferative DisorderPhase 1NCT06672705

Epcoritamab

Epcoritamab for the Treatment of Relapsed or Refractory Post Transplant Lymphoproliferative Disorders

Timothy VoorheesOpen the brief

Relapsed/Refractory Acute Myeloid LeukemiaPhase 1NCT03874052Papers

Ruxolitinib + Venetoclax

Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Jennifer SaultzOpen the brief

Clinical trials: Phase 1 and Phase 2, explained